PROVIDER PROFILE · NPI 1538168208

Julie ProssedaMD

PRACTICEPHYSICIAN MANAGEMENT SERVICES OF DELAWARE, LLCSee all providers at this practice →

Family PracticeWilmington, DEI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

2,245

Unique beneficiaries

—

Total services

3,540

Distinct HCPCS

Medicare payment

$229K

Peer benchmark

Total Medicare services vs. 294 Family Practice providers in DE — top quintile (cohort median 975).

PRESCRIBING · PART D · 2024

Total Rx claims

6,015

Beneficiaries

—

Total drug cost

$514K

Distinct drugs

113

Brand share

17.7%

Top prescribed drugs

Atorvastatin Calcium420 claims

Losartan Potassium387 claims

Rosuvastatin Calcium276 claims

Levothyroxine Sodium246 claims

Amlodipine Besylate219 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$1K

Payment records

By payment type

Food and Beverage$1K

REFERRAL NETWORK

Where Julie Prosseda's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	92	226
CHRISTIANA CARE HEALTH SERVICES, INC.	82	300
Thanh Nguyen Diagnostic Radiology · Wilmington, DE	45	74
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Norristown, PA	18	29

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history